dr. levine on the parp inhibitor landscape for ovarian cancer
Published 7 years ago • 125 plays • Length 0:52Download video MP4
Download video MP3
Similar videos
-
0:56
dr. levine on combos with parp inhibitors in ovarian cancer
-
1:17
the complexity of the parp inhibitor landscape in ovarian cancer
-
0:53
dr. levine on sequencing of agents for ovarian cancer
-
6:20
parp inhibitors in recurrent ovarian cancer
-
3:06
recurrent ovarian cancer: choosing a parp inhibitor
-
1:25
dr. konecny on the indications for parp inhibitors in recurrent ovarian cancer
-
1:44
dr. matulonis on the current treatment landscape in ovarian cancer
-
1:40
dr. hardesty on bevacizumab/parp inhibitor combination in ovarian cancer
-
6:35
parp inhibitor side effect management in ovarian cancer
-
7:34
parp inhibition’s role in recurrent ovarian cancer
-
50:29
the parp revolution: how parp inhibitors are changing the landscape of ovarian cancer treatment
-
0:48
dr. crane on the impact of parp inhibitors in ovarian cancer
-
4:30
parp inhibitors’ impact on advanced ovarian cancer
-
1:11
dr. ledermann on the additive effects of olaparib and bevacizumab in ovarian cancer
-
0:56
dr. backes on quality of life with parp inhibitors in ovarian cancer
-
1:37
dr. konecny on the use of parp inhibitors in patients with ovarian cancer
-
0:45
dr. coffman on safety concerns with parp inhibitors in ovarian cancer
-
3:44
the future role of parp inhibition in ovarian cancer
-
0:57
dr. westin on parp resistance in ovarian cancer